How Innovative Therapies are Transforming the US Cystic Fibrosis Market
In the realm of rare diseases, cystic fibrosis (CF) stands out as a significant public health challenge in the United States. As of 2024, the US cystic fibrosis market size is estimated at approximately USD 1,436.4 million, and with a promising compound annual growth rate (CAGR) of 12.95%, projections for 2035 indicate a substantial market valuation of around USD 5,484.15 million. This growth...
0 Kommentare 0 Geteilt 3 Ansichten 0 Bewertungen